September 7, 2016

Argint Voted as ‘Top 10’ Global CRO

Argint has been voted one of the top 10 global CROs based on quality of service, reputation and experience.  The voting base was 100,000 members of the Pharma IQ network. The following firms were voted to appear in the Top 10 of the chart by members of the Pharma IQ […]
Do you like it?
Read more
May 19, 2016

Press Release: ACT Oncology Wins the PACT 2016 Enterprise Award for Emerging Healthcare Companies

Flemington, N.J., May 19, 2016 – ACT Oncology announced today it has been awarded the Philadelphia Alliance for Capital and Technologies (PACT) 2016 Enterprise Award for Emerging Healthcare companies. The Enterprise Awards, held annually, are the region’s most prestigious business honors for innovative life sciences and technology companies, leaders, and entrepreneurs. […]
Do you like it?
Read more
May 4, 2016

After ACT Oncology Buy, Precision Medicine Snaps Up Applied Immunology – FierceBioTech

Fierce BioTech After ACT Oncology Buy, Precision Medicine Snaps Up Applied Immunology By Ben Adams Deal-hungry Precision Medicine has barely seen the ink dry on its March accord with a major oncology CRO before booking a new acquisition in Applied Immunology.
Do you like it?
Read more
Prev page
12345678910111213141516171819202122232425262728293031323334353637383940414243444546
Next page

Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

Visit the website